Results of radiotherapy in extranodal MALT lymphoma. A case report and literature review | Zendy

Abril Antonia Quézada Bautista | Zendy; Jorge Bejarano | Zendy; J.A. García García | Zendy; J.L. Gaxiola Sosa | Zendy; A. López Azcarraga | Zendy; María Yicel Bautista Hernández | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Results of radiotherapy in extranodal MALT lymphoma. A case report and literature review

Author(s) -

Abril Antonia Quézada Bautista,

Jorge Bejarano,

J.A. García García,

J.L. Gaxiola Sosa,

A. López Azcarraga,

María Yicel Bautista Hernández

Publication year - 2016

Publication title -

revista médica del hospital general de méxico

Language(s) - English

Resource type - Journals

eISSN - 2524-177X

pISSN - 0185-1063

DOI - 10.1016/j.hgmx.2016.04.003

Subject(s) - malt lymphoma , medicine , lymphoma , mucosa associated lymphoid tissue , radiation therapy , hodgkin lymphoma , gastroenterology , oncology

Mucosa-associated lymphoid tissue (MALT) represents 8% of non-Hodgkin lymphomas (NHL), with 2% affecting the conjunctiva. The case is presented of a 19-year-old patient diagnosed with conjunctival MALT lymphoma of the right eye, treated with external radiotherapy (ERT), and showing a complete, 100% response. At 18 months, no signs of relapse.The treatment of choice for MALT type extranodal lymphoma is ERT. It has shown excellent results in controlling the disease, overall survival, progression-free survival and relapse-free survival. The relapse rate is 6–27% and the transformation to a higher grade lymphoma between 18% and 23%, consequently patients must have adequate follow-up. If the above is confirmed, reirradiation, chemotherapy and/or molecular target-directed therapy should be considered

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research